Biblio

33557 resultats trouvés
P
Garnot B.  2014.  Prosecutors of Noon under the Old Regime. FRENCH HISTORY. 28:260-261.
Garnot B.  2014.  Prosecutors of Noon under the Old Regime. FRENCH HISTORY. 28:416-418.
Aubry S, Dubut J, Nueffer J-P, Chaigneau L, Vidal C, Kastler B.  2017.  Prospective 1-year follow-up pilot study of CT-guided microwave ablation in the treatment of bone and soft-tissue malignant tumours. EUROPEAN RADIOLOGY. 27:1477-1485.
Nicolini FE, Vantard N, Giraudier S, Heiblig M, Johnson-Ansah H, Roy L, Bulabois C-E, Caillot D, Escoffre-Barbe M, Jourdan E et al..  2014.  Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study. BLOOD. 124
Nicolini FE, Vantard N, Giraudier S, Heiblig M, Johnson-Ansah H, Roy L, Bulabois C-E, Caillot D, Escoffre-Barbe M, Jourdan E et al..  2014.  Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study. BLOOD. 124
Italiano A, Touati N, Litiere S, Collin F, Pourquier P, Gronchi A.  2018.  Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial. CANCER MEDICINE. 7:1575-1577.
Gligorov J, Pivot XB, Jacot W, Naman HL, Spaeth D, Misset J-L, Largillier R, Sautiere J-L, de Roquancourt A, Pomel C et al..  2015.  Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study. ONCOLOGIST. 20:873-879.
Scott J, Hidalgo-Mazzei D, Strawbridge R, Young A, Resche-Rigon M, Etain B, Andreassen OA, Bauer M, Bennabi D, Blamire AM et al..  2019.  Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative. INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS. 7:20.
Minon M, Soriano C, Morland D, Walter T, Lepage C, Tabarin A, Deblock M, Rousset P, Barbe C, Hoeffel C et al..  2020.  Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors. ENDOCRINE. 67:243-251.
Filleron T, Bonnetain F, Mancini J, Martinez A, Roche H, Dalenc F.  2015.  Prospective construction and validation of a prognostic score to identify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival: The METAL3 Study. CONTEMPORARY CLINICAL TRIALS. 40:1-8.
Gallian P, de Lamballerie X, Salez N, Piorkowski G, Richard P, Paturel L, Djoudi R, Leparc-Goffart I, Tiberghien P, Chiaroni J et al..  2014.  Prospective detection of chikungunya virus in blood donors, Caribbean 2014 (vol 123, pg 3679, 2014). BLOOD. 124:1695-1696.
Dumollard C., Bailly S., Perriot S., Brenier-Pinchart M.P, Saint-Raymond C., Camara B., Gangneux J.P, Persat F., Valot S., Grenouillet F. et al..  2016.  Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis. JOURNAL OF CLINICAL MICROBIOLOGY. 54:1236-1242.
Leroux D, Hezard N, Lebreton A, Bauters A, Suchon P, De Maistre E, Biron C, Huisse M-G, Ternisien C, Voisin S et al..  2014.  Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert (R) HIT) for the diagnosis of heparin-induced thrombocytopenia. BRITISH JOURNAL OF HAEMATOLOGY. 166:774-782.
Le Rhun E., C. Frenay L, Devos P., Darlix A., Lorgis V., Ahle G., Boone M., Taillandier L., Curtit E., Gras L. et al..  2018.  PROSPECTIVE EVALUATION OF ALTERNATIVE THERAPIES IN GLIOMA PATIENTS IN FRANCE. NEURO-ONCOLOGY. 20:236.
Dortet L, Cuzon G, Plesiat P, Naas T.  2016.  Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 71:135-140.
Echalier C, Sakek F, Soumagne T, Rifai SEl, Berthier F, Uhring J, Loisel F, Obert L.  2021.  Prospective evaluation of early functional recovery of displaced fractures of the middle third of the clavicle whether operated or not. ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH. 107:102768.
Moreau P, Attal M, Caillot D, Macro M, Karlin L, Garderet L, Facon T, Benboubker L, Escoffre-Barbe M, Stoppa A-M et al..  2017.  Prospective Evaluation of Magnetic Resonance Imaging and [F-18]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Tria. JOURNAL OF CLINICAL ONCOLOGY. 35:2911+.
Moreau P, Attal M, Karlin L, Garderet L, Facon T, Benboubker L, Macro M, Caillot D, Escoffre-Barbe M, Stoppa A-M et al..  2014.  Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial. BLOOD. 124
Moreau P, Attal M, Karlin L, Garderet L, Facon T, Macro M, Benboubker L, Caillot D, Escoffre M, Stoppa A-M et al..  2015.  Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial. BLOOD. 126
Moreau P, Attal M, Karlin L, Garderet L, Facon T, Benboubker L, Macro M, Caillot D, Escoffre-Barbe M, Stoppa A-M et al..  2014.  Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial. BLOOD. 124
Moreau P, Attal M, Karlin L, Garderet L, Facon T, Macro M, Benboubker L, Caillot D, Escoffre M, Stoppa A-M et al..  2015.  Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial. BLOOD. 126
Dezellus A., Barriere P., Campone M., Lemanski C., Vanlemmens L., Mignot L., Delozier T., Levy C., Bendavid C., Debled M. et al..  2017.  Prospective evaluation of serum anti-Mullerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. EUROPEAN JOURNAL OF CANCER. 79:72-80.
Angebault C, Lanternier F, Dalle F, Schrimpf C, Roupie A-L, Dupuis A, Scemla A, Paubelle E, Caillot D, Neven B et al..  2016.  Prospective Evaluation of Serum beta-Glucan Testing in Patients With Probable or Proven Fungal Diseases. OPEN FORUM INFECTIOUS DISEASES. 3
Ducassou S, Fernandes H, Savel H, Bertrand Y, Leblanc T, Chahla WAbou, Pasquet M, Leverger G, Barlogis V, Thomas C et al..  2021.  Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. JOURNAL OF PEDIATRICS. 231:223-230.
Rouzier R, Uzan C, Rousseau A, Guillot E, Zilberman S, Meyer C, Estevez P, Dupre P-F, Kere D, Doridot V et al..  2015.  Prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: The MSKCC nomogram and the Tenon score - PHRC-NOTEGS study. CANCER RESEARCH. 75

Pages